Stay updated with breaking news from Andera Midcap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tubulis today announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors
Andera Partners, a leading European private equity player, through its practice Andera Life Sciences, focused on investments in companies developing breakthrough therapeutics and medical technologies
/PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today...
- Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures - Funds
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients 22.02.2022 / 09:30 The issuer is solely responsible for the content of this announcement. PRESS RELE...